Jazz Pharmaceuticals plc (JAZZ) Operating income 2016–2025
Jazz Pharmaceuticals plc (JAZZ) annual operating income history from SEC filings — each fiscal year as reported.
-$430.2MFY2025 · since FY2016: $591.7M → -$430.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$430.2M | -160.0% |
| FY2024 | $716.6M | +23.9% |
| FY2023 | $578.6M | +983.0% |
| FY2022 | -$65.5M | -138.5% |
| FY2021 | $170.3M | -55.0% |
| FY2020 | $378.1M | -29.0% |
| FY2019 | $532.4M | -13.4% |
| FY2018 | $614.8M | +16.3% |
| FY2017 | $528.8M | -10.6% |
| FY2016 | $591.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice